2016
DOI: 10.1002/slct.201600955
|View full text |Cite
|
Sign up to set email alerts
|

Full Library of (Bis–allyl)‐deuterated Arachidonic Acids: Synthesis and Analytical Verification

Abstract: Deuteration at bis‐allylic positions slows down hydrogen abstraction, thereby reducing the rate of polyunsaturated fatty acids (PUFA) oxidation. Arachidonic acid undergoes oxidation through both enzymatic and non‐enzymatic mechanisms, giving rise to a range of important products with variable biological activity, including pro‐ and anti‐inflammatory properties. We report on the synthesis and verification of a full library of arachidonic acids variably deuterated at the bis‐allylic (C7, C10, C13) positions: 7,7… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
9

Relationship

6
3

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 49 publications
0
10
0
Order By: Relevance
“… 16 Following on this observation, if LOX-catalyzed oxidation of AA—its native substrate—plays a key role in ferroptosis execution, cells grown in media supplemented with AA labeled at the bis-allylic positions from which each LOX isoform regiospecifically abstracts a H-atom should be protected from ferroptosis. The use of regiospecifically labeled substrates 39 as isoform-selective inhibitors of LOX ( Figure 4 A, Figure S4A,B ) removes any uncertainty regarding off-target effects of inhibitors or interactions of inhibitors with the agents used to induce ferroptosis. As expected, 7,7- d 2 -AA inhibited 5-LOX activity, but not p12-LOX or 15-LOX-1 activity ( Figure 4 B), 10,10- d 2 -AA inhibited p12-LOX activity, but not 5-LOX or 15-LOX-1 activity ( Figure 4 C), and 13,13- d 2 -AA inhibited 15-LOX-1 activity, but not 5-LOX or p12-LOX activity ( Figure 4 D).…”
Section: Resultsmentioning
confidence: 99%
“… 16 Following on this observation, if LOX-catalyzed oxidation of AA—its native substrate—plays a key role in ferroptosis execution, cells grown in media supplemented with AA labeled at the bis-allylic positions from which each LOX isoform regiospecifically abstracts a H-atom should be protected from ferroptosis. The use of regiospecifically labeled substrates 39 as isoform-selective inhibitors of LOX ( Figure 4 A, Figure S4A,B ) removes any uncertainty regarding off-target effects of inhibitors or interactions of inhibitors with the agents used to induce ferroptosis. As expected, 7,7- d 2 -AA inhibited 5-LOX activity, but not p12-LOX or 15-LOX-1 activity ( Figure 4 B), 10,10- d 2 -AA inhibited p12-LOX activity, but not 5-LOX or 15-LOX-1 activity ( Figure 4 C), and 13,13- d 2 -AA inhibited 15-LOX-1 activity, but not 5-LOX or p12-LOX activity ( Figure 4 D).…”
Section: Resultsmentioning
confidence: 99%
“…D2‐Lin, D4‐Lnn , and D6‐Ara were prepared as described previously by assembling corresponding polyyne chains and subjecting them to catalytic hydrogenation. Although a similar convergent synthetic strategy, based on a Wittig olefination, was developed to obtain selectively deuterated DHA species , D10‐DHA could be prepared using the less laborious approach of catalytic H/D exchange .…”
Section: Resultsmentioning
confidence: 99%
“…Shchepinov and collegues; the synthesis and analytical verification is described elsewhere. 8 Isotopologues of arachidonic acid (AA) used in this study: 7,7-(D 2 )-AA, 10,10-(D 2 )-AA, 13,13-(D 2 )-AA, 7,7,10,10-(D 4 )-AA, 7,7,13,13-(D 4 )-AA, 10,10,13,13-(D 2 )-AA, and 7,7,10,10,13,13-(D 6 )-AA. These AA compounds were synthesized as ethyl esters for improved stability during storage.…”
Section: Methodsmentioning
confidence: 99%